Immunotherapeutic organoids: A new approach to cancer treatment
Therapeutic monoclonal antibodies have revolutionized the treatment of cancer and other diseases. However, several limitations of antibody-based treatments, such as the cost of therapy and the achievement of sustained plasma levels, should be still addressed for their widespread use as therapeutics....
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Landes Bioscience
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732323/ |